US 11266649
Pharmaceutical formulations
granted A61KA61K31/519A61K47/02
Quick answer
US patent 11266649 (Pharmaceutical formulations) held by Corvus Pharmaceuticals, Inc. expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corvus Pharmaceuticals, Inc.
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/519, A61K47/02, A61K47/14, A61K47/26